ACRIX | ACROX | ACRIX / ACROX | |
Total Expense Ratio | 1.18 | 1.26 | 94% |
Annual Report Gross Expense Ratio | 1.18 | 1.47 | 80% |
Fund Existence | 9 years | 11 years | - |
Gain YTD | 7.386 | 15.843 | 47% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000000 | 10000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.4B | 91.4M | 1,526% |
Annual Yield % from dividends | 0.52 | 1.25 | 41% |
Returns for 1 year | 1.48 | 11.88 | 12% |
Returns for 3 years | 25.50 | 50.36 | 51% |
Returns for 5 years | 38.72 | 111.98 | 35% |
Returns for 10 years | N/A | 109.53 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMQX | 19.00 | 0.15 | +0.80% |
Voya Mid Cap Research Enhanced Index A | |||
GLCRX | 30.25 | 0.18 | +0.60% |
Goldman Sachs Large Cap Gr Insghts R | |||
GCVCX | 24.22 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts C | |||
LHCVX | 18.65 | 0.05 | +0.27% |
Lord Abbett Health Care R6 | |||
POAGX | 47.89 | 0.07 | +0.15% |
PRIMECAP Odyssey Aggressive Growth |